Cargando…
Visceral Adiposity Index as an Indicator for Menstrual Disturbance, Hormonal and Metabolic Dysfunction in Polycystic Ovarian Syndrome
Background: Increase in visceral adiposity is characteristic of polycystic ovarian syndrome (PCOS) and is the main cause of insulin resistance and hyperandrogenism. This study tried to compare the visceral adiposity index (VAI) in PCOS women and control population, thereby exploring its correlation...
Autores principales: | Sharma, Priyanka, Sarkar, Avir, Kaur, Harnam, Gupta, Usha, Kumar, Binay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618402/ https://www.ncbi.nlm.nih.gov/pubmed/36340542 http://dx.doi.org/10.7759/cureus.29796 |
Ejemplares similares
-
Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome
por: Abbara, Ali, et al.
Publicado: (2019) -
Polycystic Ovarian Syndrome in Adolescents
por: Adone, Avanti, et al.
Publicado: (2023) -
Metabolic, Hormonal, Immunologic, and Genetic Factors Associated With the Incidence of Thyroid Disorders in Polycystic Ovarian Syndrome Patients
por: Singh, Jaya, et al.
Publicado: (2020) -
Insulin Resistance in Polycystic Ovarian Syndrome
por: Purwar, Ananya, et al.
Publicado: (2022) -
A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills
por: Fattah, Abdul, et al.
Publicado: (2022)